The Current Ratio as of November 2024 (TTM) for PepGen Inc. (PEPG) is 7.45

According to PepGen Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.45. This represents a change of -17.20% compared to the average of 9.00 of the last 4 quarters.

PepGen Inc. (PEPG) Historical Current Ratio (quarterly & annually)

How has PEPG Current Ratio performed in the past?

The mean historical Current Ratio of PepGen Inc. over the last ten years is 10.75. The current 7.45 Current Ratio has changed 6.83% with respect to the historical average. Over the past ten years (40 quarters), PEPG's Current Ratio was at its highest in in the September 2021 quarter at 15.99. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

PepGen Inc. (PEPG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PepGen Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PepGen Inc. (PEPG) Average Current Ratio

How has PEPG Current Ratio performed in the past?

The current Current Ratio of PepGen Inc. (PEPG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PepGen Inc. (PEPG) Current Ratio vs. Peers

How is PEPG’s Current Ratio compared to its peers?

PepGen Inc.’s Current Ratio is less than PMV Pharmaceuticals, Inc. (19.22), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (18.24), less than Pharvaris N.V. (18.45), less than Molecular Partners AG (14.58), less than Mineralys Therapeutics, Inc. (11.20), less than AN2 Therapeutics, Inc. (10.61), less than Century Therapeutics, Inc. (10.62), less than Edgewise Therapeutics, Inc. (30.24), greater than C4 Therapeutics, Inc. (6.31), less than Cullinan Oncology, Inc. (28.87), less than Tyra Biosciences, Inc. (36.46), less than Compass Therapeutics, Inc. (40.74), less than Vigil Neuroscience, Inc. (8.39), greater than PureTech Health plc (3.68), greater than Entrada Therapeutics, Inc. (5.70), less than Rallybio Corporation (7.52),

Build a custom stock screener for PepGen Inc. (PEPG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PepGen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PepGen Inc. (PEPG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PepGen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.